tiprankstipranks
Trending News
More News >
Defence Therapeutics (DTCFF)
OTHER OTC:DTCFF
US Market

Defence Therapeutics (DTCFF) Financial Statements

Compare
26 Followers

Defence Therapeutics Financial Overview

Defence Therapeutics's market cap is currently $25.65M. The company's EPS TTM is $-0.020521088; its P/E ratio is -7.61; Defence Therapeutics is scheduled to report earnings on February 20, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 25Jun 24Sep 23Sep 22Sep 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -72.34KC$ -90.92KC$ -13.82KC$ 0.00C$ 0.00
Operating IncomeC$ -3.27MC$ -12.66MC$ -6.55MC$ -3.56MC$ -2.86M
EBITDAC$ -3.13MC$ -12.68MC$ -6.48MC$ 0.00C$ 0.00
Net IncomeC$ -3.52MC$ -13.19MC$ -6.76MC$ -7.34MC$ -2.86M
Balance Sheet
Cash & Short-Term InvestmentsC$ 1.23MC$ 56.55KC$ 2.79MC$ 506.70KC$ 5.45M
Total AssetsC$ 1.65MC$ 477.75KC$ 3.53MC$ 719.67KC$ 5.61M
Total DebtC$ 1.50MC$ 1.75MC$ 1.75MC$ 0.00C$ 0.00
Net DebtC$ 271.84KC$ 1.69MC$ -1.05MC$ -506.70KC$ -5.45M
Total LiabilitiesC$ 2.91MC$ 4.06MC$ 1.97MC$ 1.11MC$ 122.26K
Stockholders' EquityC$ -1.26MC$ -3.58MC$ 1.57MC$ -387.56KC$ 5.49M
Cash Flow
Free Cash FlowC$ -3.40MC$ -4.49MC$ -7.72MC$ -6.04MC$ -2.29M
Operating Cash FlowC$ -3.40MC$ -4.29MC$ -7.66MC$ -6.04MC$ -2.29M
Investing Cash FlowC$ 3.60KC$ -203.24KC$ -65.80KC$ 0.00C$ 0.00
Financing Cash FlowC$ 4.57MC$ 1.76MC$ 10.01MC$ 1.10MC$ 5.88M
Currency in CAD

Defence Therapeutics Earnings and Revenue History

Defence Therapeutics Debt to Assets

Defence Therapeutics Cash Flow

Defence Therapeutics Forecast EPS vs Actual EPS